Mundipharma and CellAct announce new deal for the worldwide development and commercialization of smart chemotherapy CAP7.1
CellAct - MundiPharma Press Release (106kb): 
CellAct ASCO 3.6 2016: CellAct Pharma Phase 2 CAP7.1 Population Pharmacokinetic Data Supports Efficacy Results in Biliary Tract Cancers
CellAct ASCO 2016.pdf (97kb):
CellAct Pharma Presents Interim Phase 2 Data Showing CAP7.1 Initial Efficacy in Biliary Tract Cancers at ASCO GI
ASCO GI 25.1.16.pdf (99kb):
CellAct Pharma Presents Interim Phase 2 Data Showing CAP7.1 Initial Efficacy in Biliary Tract Cancers at ASCO GI
ASCO GI 25.1.16.pdf (99kb):
| 
